Molecular Targets of Tannic Acid in Alzheimer's Disease

被引:39
|
作者
Braidy, Nady [1 ,2 ]
Jugder, Bat-Erdene [2 ]
Poljak, Anne [1 ,3 ]
Jayasena, Tharusha [1 ]
Nabavi, Seyed Mohammad [4 ]
Sachdev, Perminder [1 ,5 ]
Grant, Ross [3 ,6 ,7 ]
机构
[1] Univ New South Wales, Sch Psychiat, Ctr Hlth Brain Ageing, Sydney, NSW, Australia
[2] Univ New South Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia
[3] Univ New South Wales, Sch Med Sci, Sydney, NSW, Australia
[4] Baqiyatallah Univ Med Sci, Appl Biotechnol Res Ctr, Tehran, Iran
[5] Prince Wales Hosp, Neuropsychiat Inst, Sydney, NSW, Australia
[6] Sydney Adventist Hosp, Australasian Res Inst, Sydney, NSW, Australia
[7] Univ Sydney, Sydney Med Sch, Sydney, NSW, Australia
基金
英国医学研究理事会; 澳大利亚国家健康与医学研究理事会;
关键词
Tannic acid; Alzheimer's disease; A beta pathology; tau; beta-secretase; neurons; AMYLOID PRECURSOR PROTEIN; MEMAPSIN-2; BETA-SECRETASE; DENDRITIC SPINE PATHOLOGY; GALLIC ACID; TAU-PROTEIN; COGNITIVE IMPAIRMENT; CEREBRAL-HEMORRHAGE; ACUTE TOXICITY; CELL BIOLOGY; HUMAN HEALTH;
D O I
10.2174/1567205014666170206163158
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Tannic acid (TA) is a naturally occurring plant-derived polyphenol found in several herbaceous and woody plants, including legumes, sorghum, beans, bananas, persimmons, rasberries, wines and a broad selection of teas. Clinically, TA has strong antioxidant/free radical scavenging, antiinflammatory, anti-viral/bacterial, and anti-carcinogenic properties. While the aetiology of Alzheimer's disease (AD) remains unclear, this complex multifactorial neurodegenerative disorder remains the most common form of dementia, and is a growing public health concern worldwide. The neuroprotective effects of TA against AD have been shown in several in vitro and in vivo models of AD. Apart from its potent antioxidant and anti-inflammatory roles, evidence suggests that TA is also a natural inhibitor of beta-secretase (BACE1) activity and protein expression. BACE1 is the primary enzyme responsible for the production and deposition of A beta peptide. TA also destabilises neurotoxic amyloid beta (A beta) fibrils in vitro. Apart from its effects on the A beta cascade, TA can also inhibit the in vitro aggregation of tau peptide, a core component of intracellular neurofibrillary tangles (NFTs). This review summarizes the relevance of TA and TA-related vegetable extracts (tannins) in the pathogenesis of AD and its enzymatic targets. It also highlights the significance of TA as an important lead compound against AD.
引用
收藏
页码:861 / 869
页数:9
相关论文
共 50 条
  • [31] Retinoids as potential targets for Alzheimer's disease
    Sodhi, Rupinder K.
    Singh, Nirmal
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2014, 120 : 117 - 123
  • [32] Tropisetron and its targets in Alzheimer's disease
    Hashimoto, Kenji
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2015, 19 (01) : 1 - 5
  • [33] Metal and inflammatory targets for Alzheimer's disease
    Rogers, JT
    Lahiri, DK
    CURRENT DRUG TARGETS, 2004, 5 (06) : 535 - 551
  • [34] New kinase targets for Alzheimer's disease
    Monica Hoyos Flight
    Nature Reviews Drug Discovery, 2013, 12 : 739 - 739
  • [35] Alzheimer's Disease: Targets For Drug Development
    Larner, A. J.
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2002, 2 (01) : 3 - 11
  • [36] Alzheimer's Disease and Cancer: Common Targets
    Yang, Xueqing
    Dai, Jinlian
    Wu, Chenglong
    Liu, Zongliang
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2024, 24 (10) : 983 - 1000
  • [37] Secretases as therapeutic targets for Alzheimer's disease
    Woo, Ha-Na
    Baik, Sang-Ha
    Park, Jong-Sung
    Gwon, A-Ryeong
    Yang, Sunghee
    Yun, Young-Kwang
    Jo, Dong-Gyu
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2011, 404 (01) : 10 - 15
  • [38] New Therapeutic Targets in Alzheimer's Disease
    Coman, Horia
    Nemes, Bogdan
    INTERNATIONAL JOURNAL OF GERONTOLOGY, 2017, 11 (01) : 2 - 6
  • [39] Druggable targets for the immunopathy of Alzheimer's disease
    Weaver, Donald F.
    RSC MEDICINAL CHEMISTRY, 2023, 14 (09): : 1645 - 1661
  • [40] Possible treatment targets in Alzheimer’s disease
    A. Pryce Roberts
    N. P. Robertson
    Journal of Neurology, 2013, 260 (12) : 3193 - 3196